Skip to Content is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in News for Health Professionals

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 3 to 7, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. U.S. Cancels Blanket Warning for International...

Posted today in Medical

Simple Test Shows Which Face Masks Are Best

When it comes to face masks, not all are equally effective, a new study finds. Duke University researchers developed a way of testing various types of masks to see which did the best job of stopping droplets coming from people's mouths, preventing spread of the new coronavirus. They relied on a makeshift apparatus consisting of a box, a laser, a lens...

Posted today in Medical

Baby's Meningitis Case Highlights Growing Danger of Antibiotic Resistance

Antibiotic-resistant bacteria affected the treatment of meningitis at a major children's hospital in Washington, D.C. This single case at Children's National Hospital raises concerns about drug resistance in the common bacterium that caused the infection, and researchers say it could change lab and clinical procedures around the world. Normally, when...

Posted 3 days ago in New Drug Approvals

FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

GlaxoSmithKline announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory agent....

Posted 3 days ago in News for Health Professionals

Number of Newly ID'd U.S. Patients With Cancer Dropped During COVID-19

During the COVID-19 pandemic period, there was a significant decline in newly identified U.S. patients with six common types of cancer, according to a research letter published online Aug. 4 in JAMA Network Open. Harvey W. Kaufman, M.D., from Quest Diagnostics in Secaucus, New Jersey, and colleagues analyzed weekly changes in the number of patients...

Posted today in News for Health Professionals

In Wales, One-Fifth of Adults With Hearing Aids Do Not Use Them

About 20 percent of adults with hearing aids in Wales, the United Kingdom, do not use them, according to a study recently published in the International Journal of Audiology. Harvey Dillon, Ph.D., from the University of Manchester in the United Kingdom, and colleagues extracted national household survey data from 2004 to 2018 in Wales to examine the...

Posted today in News for Health Professionals

300,000 American Deaths Projected by December Without More Face Mask Use

As the U.S. COVID-19 case count neared 5 million on Thursday, a new model predicted that nearly 300,000 Americans could die of COVID-19 by December if more people do not wear masks or practice better social distancing. Researchers from the University of Washington Institute for Health Metrics and Evaluation (IHME) on Thursday issued a forecast of 295,011...

Posted today in News for Health Professionals

Trouble With Daily Activities Tied to Worse Cancer Outcomes

Hospitalized patients with advanced cancer who have difficulty with activities of daily living (ADLs) experience worse clinical outcomes, according to a study recently published in the Journal of the National Comprehensive Cancer Network. Daniel E. Lage, M.D., from Massachusetts General Hospital in Boston, and colleagues assessed patients' ability...

Posted today in News for Health Professionals

Almost One in Three Black Young Adults in U.S. Have Hypertension

Nearly one in three young non-Hispanic black adults and about one in five young Mexican-American and non-Hispanic white adults have hypertension, according to a study published in the July 1 issue of Mayo Clinic Proceedings. Vibhu Parcha, M.D., from University of Alabama at Birmingham, and colleagues used data from the National Health and Nutrition...

Posted today in News for Health Professionals

U.S. Cancels Blanket Warning for International Travel

On Thursday, the Trump administration canceled its warnings against international travel because of the COVID-19 pandemic, the Associated Press reported. Conditions no longer call for a blanket worldwide alert, the administration said. The State Department lifted its worldwide health advisory and returned to country-specific warnings, the AP said....

Read more news...

Recently added consumer and prescribing information: Monjuvi, Tecartus, Xeglyze, Breztri Aerosphere, Inqovi, Rukobia, Qwo, Gimoti, Dojolvi, Mycapssa

Posted in Blog

Feeling the heat? Maybe your medication is to blame.

With the weather heating up across the U.S. it seems good timing that most states are easing their lockdown restrictions. Escaping into the sun is something we are all looking forward to, especially after a winter of confinement at home. But did you know that heat-related deaths are one of the deadliest weather-related outcomes in […]

Posted in Blog

Vitamin C: Time to take this supplement seriously?

Vitamin C has always been a controversial supplement. To some, it belongs firmly in the alternative medicine basket, with apparently no substantial evidence to support its use. To others, it holds promise, particularly if you are talking about certain groups of people who are likely to be low in vitamin C. Because we NEED vitamin […]

Posted in Blog

Medical Advances Amidst COVID-19 Chaos

Undeniably, we are in unprecedented times. COVID-19 is a serious and fatal disease for some and globally it has, and will continue to have, wide-reaching implications, medically, socially, and financially for some time. But medical advances will be significant. Although we have learned a lot about the new coronavirus already, there is still a lot […]

See more blog posts or follow us on twitter.